The LMNA-NTRK1 fusion-positive tumor was difficult to diagnose before RNA sequencing by NGS because of its unusual pathology and immunohistochemical profile, namely, a combination of prominent inflammatory cells, no mitotic activity (0/10 HPF), and S100/CD34 coexpression. Here, CD34 is linked to neoplasm.